Wanguang Zhang

16PUBLICATIONS
37CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 14, 2026
Utility of the Iwate Difficulty Scoring System for the Stratification of Laparoscopic Right Hepatectomies: An International Multicenter Study.

|Mar 23, 2026
Liver resection versus transarterial chemoembolization plus PD-1 inhibitors and lenvatinib for hepatocellular carcinoma with portal vein tumour thrombus.

Bin Guo, Shaliheng Yerken, Chu Luo

|Jul 21, 2025
The Role of Lactate in Cancer Immunotherapy: Mechanisms and Applications.

Yunhui Fan, Haoyue Jia, Wanguang Zhang

|Jun 27, 2025
Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti-PD-1 resistance in hepatocellular carcinoma.

Junnan Liang, Jingyu Liao, Ruizhi Chang

|May 30, 2025
Simvastatin overcomes the pPCK1-pLDHA-SPRINGlac axis-mediated ferroptosis and chemo-immunotherapy resistance in AKT-hyperactivated intrahepatic cholangiocarcinoma.

Jinghan Zhu, Yixiao Xiong, Yuxin Zhang

|Oct 25, 2024
Lactylation-Driven IGF2BP3-Mediated Serine Metabolism Reprogramming and RNA m6A-Modification Promotes Lenvatinib Resistance in HCC.

Yuanxiang Lu, Jinghan Zhu, Yuxin Zhang

Pageof 3

Frequent Collaborators

4 joint publications

Huifang Liang

2 joint publications

Jinghan Zhu

1 joint publications

Lei Zhang

1 joint publications

Hong-Ping Luo